| scholarly article | Q13442814 |
| P50 | author | Irene Latorre | Q40808679 |
| Irma Casas | Q42241696 | ||
| José Domínguez | Q43147728 | ||
| Alicia Lacoma | Q50883756 | ||
| Maria Luiza De Souza Galvão | Q73568275 | ||
| Tom H M Ottenhoff | Q87817901 | ||
| Cristina Prat | Q114907818 | ||
| P2093 | author name string | Cèlia Milà | |
| Jéssica Díaz | |||
| Jordi Solsona | |||
| José Maldonado | |||
| Juan Ruiz-Manzano | |||
| Kees L C M Franken | |||
| M Ángeles Jimenez-Fuentes | |||
| Mᵃdel Mar Serra-Vidal | |||
| Neus Altet | |||
| Vicente Ausina | |||
| P2860 | cites work | Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis | Q24537176 |
| A bacterial cytokine | Q24678303 | ||
| Vaccines against tuberculosis: where are we and where do we need to go? | Q26992233 | ||
| The enduring hypoxic response of Mycobacterium tuberculosis | Q27302134 | ||
| BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease | Q41379320 | ||
| An unbiased genome-wide Mycobacterium tuberculosis gene expression approach to discover antigens targeted by human T cells expressed during pulmonary infection | Q42278752 | ||
| T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia | Q43414665 | ||
| Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria | Q43487749 | ||
| Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection | Q43788197 | ||
| Interferon-γ responses to Mycobacterium tuberculosis Rpf proteins in contact investigation. | Q45105159 | ||
| Interpretation of Mycobacterium tuberculosis antigen-specific IFN-gamma release assays (T-SPOT.TB) and factors that may modulate test results | Q46562209 | ||
| Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis | Q46846362 | ||
| Interferon gamma production in the course of Mycobacterium tuberculosis infection. | Q51820041 | ||
| Profiling of Mycobacterium tuberculosis gene expression during human macrophage infection: upregulation of the alternative sigma factor G, a group of transcriptional regulators, and proteins with unknown function. | Q54617450 | ||
| Diagnóstico y tratamiento de la tuberculosis | Q56762814 | ||
| Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis | Q57223767 | ||
| Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children | Q58924852 | ||
| The genetics of vulnerability | Q59098584 | ||
| Purification of his-tagged proteins by immobilized chelate affinity chromatography: the benefits from the use of organic solvent | Q73386350 | ||
| Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment | Q74844612 | ||
| Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society | Q28139982 | ||
| Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment | Q28487339 | ||
| The growing burden of tuberculosis: global trends and interactions with the HIV epidemic | Q29616520 | ||
| An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
| Disseminated tuberculosis in interferon gamma gene-disrupted mice | Q29619812 | ||
| Drug-resistant tuberculosis: time for visionary political leadership | Q30428762 | ||
| Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses | Q31156691 | ||
| The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis | Q33325926 | ||
| Functional genetic diversity among Mycobacterium tuberculosis complex clinical isolates: delineation of conserved core and lineage-specific transcriptomes during intracellular survival | Q33632198 | ||
| Specific immune-based diagnosis of tuberculosis | Q34048117 | ||
| Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting | Q34133162 | ||
| Variation in protection by BCG: implications of and for heterologous immunity | Q34288541 | ||
| Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis | Q34429275 | ||
| Mycobacterial persistence: adaptation to a changing environment | Q34453443 | ||
| How can immunology contribute to the control of tuberculosis? | Q34572120 | ||
| Effector and memory T-cell differentiation: implications for vaccine development | Q34632071 | ||
| Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa | Q34989726 | ||
| Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals | Q35066262 | ||
| Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load | Q35175755 | ||
| Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination | Q35913675 | ||
| Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies | Q36238015 | ||
| Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice | Q36402431 | ||
| Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis | Q36505201 | ||
| Mycobacterium bovis BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy | Q36710576 | ||
| Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis. | Q36919069 | ||
| Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection | Q37186665 | ||
| Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa | Q37301865 | ||
| The temporal expression profile of Mycobacterium tuberculosis infection in mice. | Q37358252 | ||
| Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria | Q37410301 | ||
| Hypoxia: a window into Mycobacterium tuberculosis latency | Q37456945 | ||
| Tuberculosis vaccine development: strength lies in tenacity | Q38007729 | ||
| The immunological life cycle of tuberculosis | Q38025869 | ||
| How to use: interferon γ release assays for tuberculosis | Q38098496 | ||
| Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria | Q39585291 | ||
| Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis | Q40239843 | ||
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 517 | |
| P577 | publication date | 2014-10-08 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Immunogenicity of 60 novel latency-related antigens of Mycobacterium tuberculosis | |
| P478 | volume | 5 |
| Q52655450 | A High Throughput Whole Blood Assay for Analysis of Multiple Antigen-Specific T Cell Responses in Human Mycobacterium tuberculosis Infection. |
| Q59341021 | A Systematic Review on Novel Antigens and Their Discriminatory Potential for the Diagnosis of Latent and Active Tuberculosis |
| Q36814846 | A putative nitroreductase from the DosR regulon of Mycobacterium tuberculosis induces pro-inflammatory cytokine expression via TLR2 signaling pathway |
| Q40062509 | Altered expression of antigen-specific memory and regulatory T cell subsets differentiate latent and active Tuberculosis |
| Q89965652 | Cell-Mediated Immune Responses to in vivo-Expressed and Stage-Specific Mycobacterium tuberculosis Antigens in Latent and Active Tuberculosis Across Different Age Groups |
| Q41697005 | Circulating Mycobacterium tuberculosis DosR latency antigen-specific, polyfunctional, regulatory IL10+ Th17 CD4 T-cells differentiate latent from active tuberculosis |
| Q38849398 | Comprehensive definition of human immunodominant CD8 antigens in tuberculosis |
| Q98237590 | Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination |
| Q26783147 | Dormancy antigens as biomarkers of latent tuberculosis infection |
| Q64257681 | Evidence for Highly Variable, Region-Specific Patterns of T-Cell Epitope Mutations Accumulating in Strains |
| Q38383317 | Host immunity to Mycobacterium tuberculosis and risk of tuberculosis: A longitudinal study among Greenlanders. |
| Q40120455 | Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio). |
| Q38620366 | Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines |
| Q41503092 | Mycobacterium tuberculosis dormancy-associated antigen of Rv2660c induces stronger immune response in latent Mycobacterium tuberculosis infection than that in active tuberculosis in a Chinese population |
| Q50494715 | Mycobacterium tuberculosis gene expression at different stages of hypoxia-induced dormancy and upon resuscitation. |
| Q37445202 | New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles |
| Q37685973 | Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K. |
| Q47150163 | ORFeome-based identification of biomarkers for serodiagnosis of Mycobacterium tuberculosis latent infection |
| Q38378581 | Proteomic analysis of protein purified derivative of Mycobacterium bovis |
| Q61446166 | Recombinant O-mannosylated protein production (PstS-1) from Mycobacterium tuberculosis in Pichia pastoris (Komagataella phaffii) as a tool to study tuberculosis infection |
| Q38880052 | Resuscitation-promoting factors are important determinants of the pathophysiology in Mycobacterium tuberculosis infection. |
| Q41672090 | Significance of antigen and epitope specificity in tuberculosis |
| Q36278447 | Species dependent impact of helminth-derived antigens on human macrophages infected with Mycobacterium tuberculosis: Direct effect on the innate anti-mycobacterial response. |
| Q61449784 | Study of CD27 and CCR4 Markers on Specific CD4 T-Cells as Immune Tools for Active and Latent Tuberculosis Management |
| Q37679327 | The bacillary and macrophage response to hypoxia in tuberculosis and the consequences for T cell antigen recognition |
| Q92106827 | Two-Hit in vitro T-Cell Stimulation Detects Mycobacterium tuberculosis Infection in QuantiFERON Negative Tuberculosis Patients and Healthy Contacts From Ghana |
Search more.